Ben Dickinson – Page 3 – Biosimilars Adoption | Breaking through Barriers

The U.S. Generic & Biosimilar Medicines Savings Report (Sep. 2022)

The Global Use of Medicines 2023

Real-world evidence of a successful biosimilar adoption program

National trends in prescription drug expenditures and projections for 2022

Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care

Natalizumab REMS Strategy

The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review

Efficacy and Safety of Proposed Biosimilar Natalizumab (PB006) in Patients With Relapsing-Remitting Multiple Sclerosis

Biosimilar Drugs for Multiple Sclerosis: An Unmet International Need or a Regulatory Risk?

An Update Review of Biosimilars of Adalimumab in Psoriasis – Bioequivalence and Interchangeability